Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|April 13, 2023
Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5-year follow-up data from the prospective BioCrohn studyBernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, et al.Zeitschrift Fur Gastroenterologie|July 10, 2019
Real-world biologic treatment and associated cost in patients with inflammatory bowel diseaseAlina Brandes, Antje Groth, Fraence Gottschalk, et al.Journal of Crohn'S & Colitis|January 21, 2012
Predictors for subsequent need for immunosuppressive therapy in early Crohn's diseaseSandra Wenger, Susanna Nikolaus, Stefanie Howaldt, et al.International Journal of Colorectal Disease|January 27, 2022
Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL studyCarsten Schmidt, Bernd Bokemeyer, Andreas Lügering, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 23, 2017
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel diseaseJames O Lindsay, Alessandro Armuzzi, Javier P Gisbert, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 13, 2016
[Inflammatory Bowel Disease Competence Network]Stefan Schreiber, Heinz Hartmann, Wolfgang Kruis, et al.Digestion|October 23, 2019
Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data AnalysisAntje Mevius, Alina Brandes, Fränce Hardtstock, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2012
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel diseaseRayko Evstatiev, Olga Alexeeva, Bernd Bokemeyer, et al.Therapeutic Advances in Gastroenterology|August 1, 2024
Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysisEvi Zhuleku, Daniel Wirth, Riikka Nissinen, et al.Zeitschrift Fur Gastroenterologie|May 13, 2017
Azathioprine allows glucocorticoid withdrawal - post hoc results of a prospective study in patients with inflammatory bowel diseasesNiels Teich, Wolfgang Mohl, Bernd Bokemeyer, et al.Pageof 8